December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Treatment of Polypoidal Choroidal Vasculopathy with Photodynamic Therapy
Author Affiliations & Notes
  • RF Spaide
    Vitreous Ret-Macula Cnslts NY New York NY
  • LA Yannuzzi
    Vitreous Ret-Macula Cnslts NY New York NY
  • LM Jampol
    Ophthalmology Northwestern University Medical School Chicago IL
  • J Slakter
    Vitreous Ret-Macula Cnslts NY New York NY
  • J Sorenson
    Vitreous Ret-Macula Cnslts NY New York NY
  • K Freund
    Vitreous Ret-Macula Cnslts NY New York NY
  • Footnotes
    Commercial Relationships   R.F. Spaide, None; L.A. Yannuzzi, None; L.M. Jampol, Novartis Ophthalmics C, R; J. Slakter, Novartis Ophthalmics C, R; J. Sorenson, None; K. Freund, None. Grant Identification: Research to Prevent Blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 3982. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      RF Spaide, LA Yannuzzi, LM Jampol, J Slakter, J Sorenson, K Freund; Treatment of Polypoidal Choroidal Vasculopathy with Photodynamic Therapy . Invest. Ophthalmol. Vis. Sci. 2002;43(13):3982.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To study the effects of photodynamic therapy using verteporfin in the treatment of patients with subfoveal polypoidal choroidal vasculopathy (PCV). Methods:A retrospective chart review of 17 consecutive patients with subfoveal PCV treated with photodynamic therapy using verteporfin was performed. Results:The mean age of the patients involved was 70.6 years. The mean follow-up time was 10 months. The visual acuity improved in 10 (58.8 %), remained the same in 6 (35.3 %), and decreased in 1 (5.9 %). The mean change in visual acuity was an improvement of 2.23 lines, a difference that was highly significant (p =.001). The change in visual acuity was negatively correlated with increasing age. The final visual acuity was positively correlated with initial acuity and negatively correlated with age. These results were confirmed by multiple linear regression. No patient had any lasting complication from the treatment. Conclusion:Although the follow-up time and the number of patients in this pilot study were limited, the encouraging results and lack of complications suggest that further study is indicated.

Keywords: 516 photodynamic therapy • 346 choroid: neovascularization • 308 age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×